Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jul 1;20(4):e435-40.
doi: 10.4317/medoral.20410.

Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial

Begoña Palacios-Sánchez  1 , Luis-Alberto Moreno-López, Rocío Cerero-Lapiedra, Silvia Llamas-Martínez, Germán Esparza-Gómez
Affiliations
Randomized Controlled Trial

Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial

Begoña Palacios-Sánchez et al. Med Oral Patol Oral Cir Bucal. .

Abstract

Background: A double-blind placebo-controlled trial was conducted in order to evaluate the efficacy of alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables. Burning mouth syndrome (BMS) is defined as an oral burning sensation in the absence of clinical signs which could justify the syndrome. Recent studies suggest the existence of neurological factors as a possible cause of the disease.

Material and methods: 60 patients with BMS, in two groups: case group with 600 mg/day and placebo as control group; with follow up of 2 months.

Results: 64% of ALA patients reported some level of improvement, with a level of maintenance of 68.75% one month after treatment. 27.6% of the placebo group also demonstrated some reduction in BMS symptoms.

Conclusions: Long-term evolution and the intensity of symptoms are variables that reduce the probability of improvement with ALA treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors have declared that no conflict of interest exist.

Figures

Figure 1
Figure 1
Influence of Variables in treatment response to ALA (% ). (Negative values indicate worse response to ALA).
See this image and copyright information in PMC

References

    1. Merskey II , Bogduk N . Classification of Headache disorders. 2nd edition. New-York: Seattle: International Association for the Study of Pain ; 2004. pp. 9–205.
    1. Rhodus NL, Carlson CR, Miller CS. Burning mouth (syndrome) disorder. Quintessence Int. 2003;34:587–93. - PubMed
    1. Lamey PJ, Lewis MA. Oral medicine in practice: burning mouth syndrome. Br Dent J. 1989;167:197–200. - PubMed
    1. Minguez-Sanz MP, Salort-Llorca C, Silvestre-Donat FJ. Etiology of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal. 2011;16:e144–8. - PubMed
    1. Tourne LP, Fricton JR. Burning mouth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol. 1992;74:158–67. - PubMed

Publication types